Evogene Ltd. (TLV:EVGN)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
392.20
-28.30 (-6.73%)
Apr 24, 2025, 5:24 PM IDT
-83.30%
Market Cap 25.34M
Revenue (ttm) 31.00M
Net Income (ttm) -60.04M
Shares Out 6.51M
EPS (ttm) -10.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 65,718
Average Volume 61,711
Open 409.00
Previous Close 420.50
Day's Range 385.00 - 409.00
52-Week Range 357.30 - 2,989.00
Beta 1.18
RSI 35.80
Earnings Date May 20, 2025

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 117
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol EVGN
Full Company Profile

Financial Performance

In 2024, Evogene's revenue was $8.51 million, an increase of 50.90% compared to the previous year's $5.64 million. Losses were -$16.49 million, -30.96% less than in 2023.

Financial numbers in USD Financial Statements

News

ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio

Lavie Bio improves agriculture productivity and sustainability through microbiome-based ag-biological products REHOVOT, Israel , April 21, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN)...

5 days ago - PRNewsWire

Evogene appoints Nir Nimrodi as new chair

7 weeks ago - Seeking Alpha

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results

Conference call and webcast: today, March 6, 2025, 9:00 am ET Financial Highlights: In the year 2024, total revenues reached approximately $8.5 million compared to approximately $5.6 million in the ye...

7 weeks ago - PRNewsWire

Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025

Mr. Nir Nirmodi is Replacing Ms. Sarit Firon, who will Continue Serving as a Member of the Board REHOVOT, Israel , March 6, 2025 /PRNewswire/ -- Evogene Ltd.

7 weeks ago - PRNewsWire

Earnings Scheduled For March 6, 2025

Companies Reporting Before The Bell • Priority Tech Holdings (NASDAQ: PRTH) is expected to report quarterly earnings at $0.07 per share on revenue of $227.93 million. • KVH Industries (NASDAQ: KVHI)...

7 weeks ago - Benzinga

Evogene Q4 2024 Earnings Preview

7 weeks ago - Seeking Alpha

Evogene Schedules Fourth Quarter 2024 Financial Results Release

Zoom conference call scheduled for March 6, 2025, 9:00 AM ET REHOVOT, Israel , Feb. 20, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting...

2 months ago - PRNewsWire

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease

Initial fungicidally active compounds already discovered REHOVOT, Israel , Feb. 13, 2025 /PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection pr...

2 months ago - PRNewsWire

Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities

Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities

5 months ago - GuruFocus

Evogene Reports Third Quarter 2024 Financial Results

Conference call and webcast: today, November 21, 2024, 9:00 am ET Financial Highlights: In the first nine months of 2024, total revenues reached approximately $6.9 million, compared to approximately $...

5 months ago - PRNewsWire

Evogene Q3 2024 Earnings Preview

5 months ago - Seeking Alpha

A Glimpse of Evogene's Earnings Potential

Evogene (NASDAQ: EVGN) will release its quarterly earnings report on Thursday, 2024-11-21. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Evogene to report an ea...

5 months ago - Benzinga

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

LAV321demonstrated strong results in its third consecutive year of field trials in Europe REHOVOT, Israel , Nov. 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and subsidiar...

5 months ago - PRNewsWire

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

Lavie Bio intends to commence Yalos® sales for soybean in 2025 US spring season   REHOVOT, Israel , Nov. 12, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of E...

5 months ago - PRNewsWire

Evogene Schedules Third Quarter 2024 Financial Results Release

Zoom conference call scheduled for November 21, 2024, 9:00 AM ET REHOVOT, Israel , Nov. 7, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company target...

6 months ago - PRNewsWire

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design

The collaboration has the power to foster breakthroughs in small molecule innovation for life science-based products REHOVOT, Israel , Oct. 31, 2024 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: ...

6 months ago - PRNewsWire

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

The shipment, comprising over 100 tons, was delivered to company's customer in Africa REHOVOT, Israel , Oct. 29, 2024 /PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation so...

6 months ago - PRNewsWire

Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology

Following a successful first year, Israel Innovation Authority (IIA) approved financing second year of collaboration HAZEVA and REHOVOT, Israel , Oct. 8, 2024 /PRNewswire/ -- Watershed AC ("Watershed"...

7 months ago - PRNewsWire

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals

The technology aims to reduce application costs, extend shelf life, and prolong bacterial viability after field application REHOVOT, Israel , Sept. 30, 2024 /PRNewswire/ -- Lavie Bio Ltd.

7 months ago - PRNewsWire

Evogene prices $5.5M direct offering

8 months ago - Seeking Alpha

Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement

REHOVOT, Israel , Aug. 23, 2024 /PRNewswire/ -- Evogene Ltd. ("Evogene" or the "Company") (NASDAQ: EVGN , TASE: EVGN)), a leading computational biology company aiming to revolutionize life-science-bas...

8 months ago - Benzinga